HOUSTON (AP) — HOUSTON (AP) — Cerenome, Inc. (CNSY) on Friday reported a loss of $9 million in its second quarter.
On a per-share basis, the Houston-based company said it had a loss of $1.31.
The developer of cell therapies posted revenue of $411,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNSY at https://www.zacks.com/ap/CNSY
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
